Gregory A. Gfesser - Concepedia

Author

Gregory A. Gfesser

Abbott Fund

Also Known As

G. A. GFESSER, G. A. Gfesser, G. Gfesser, Gfesser, Gregory A., Gregory A Gfesser, Gregory A. Gfesser

Publications

697

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United Kingdom)AbbVie (United States)

About

Gregory A. Gfesser is an author at Abbott Fund specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	413
2	Biochemistry	6	6	250
3	Natural Sciences	3	3	121
4	Engineering	2	2	52
5	Social Sciences	1	1	121

Gregory A. Gfesser

Publications

616

Citations

H-Index

Page 1

	Year	Citations
4-(2-[2-(2(<i>R</i>)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H<sub>3</sub> Receptor Antagonists Potently Enhance Cognition and Attention Marlon Cowart, Ramin Faghih, Michael P. Curtis, Journal of Medicinal Chemistry Receptor AntagonistsPsychopharmacologyPharmacotherapyAttentionSocial Sciences	2004	121
Synthesis and SAR of 5-Amino- and 5-(Aminomethyl)benzofuran Histamine H<sub>3</sub>Receptor Antagonists with Improved Potency Minghua Sun, Chen Zhao, Gregory A. Gfesser, Journal of Medicinal Chemistry	2005	62
Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Ramin Faghih, Sujatha M. Gopalakrishnan, Jens Halvard Grønlien, Journal of Medicinal Chemistry	2009	53
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure–activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors Mark A. Matulenko, Chih‐Hung Lee, Meiqun Jiang, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2005	48
Structure–activity relationships of arylbenzofuran H3 receptor antagonists Gregory A. Gfesser, Ramin Faghih, Youssef L. Bennani, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionPharmacological Agent	2005	47
Adenosine kinase inhibitors: polar 7-Substitutent of pyridopyrimidine derivatives improving their locomotor selectivity Guo Zhu Zheng, Yue Mao, Chih‐Hung Lee, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPyridopyrimidine DerivativesMolecular PhysiologyBiochemistryFunctional Selectivity	2003	43
Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors Gregory A. Gfesser, Erol K. Bayburt, Marlon Cowart, European Journal of Medicinal Chemistry Molecular Pharmacology5-Heteroatom-substituted PyridopyrimidinesBiochemistryMedicineStructure-activity Relationships	2003	41
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists Arthur Gomtsyan, Robert G. Schmidt, Erol K. Bayburt, Journal of Medicinal Chemistry Pain MedicineNeuropathic PainMolecular PainPharmacotherapyExperimental Pharmacology	2016	37
Lewis Acid-Promoted Reactions of Unsymmetrically Substituted Stilbenes with 2-Methoxy-1,4-benzoquinones: Stereoselective Synthesis of trans-2,3-Diaryl-2,3-dihydrobenzofurans Thomas A. Engler, Gregory A. Gfesser, Bill W. Draney The Journal of Organic Chemistry Unsymmetrically Substituted StilbenesDerivativesEngineeringHeterocyclicDonut Icon	1995	36
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis Marc J. C. Scanio, Xenia B. Searle, Bo Liu, ACS Medicinal Chemistry Letters	2019	36

Page 1